O. Public Health (Issues pertaining to preparedness for and response to outbreaks including those linked to agents of bioterror, foodborne, waterborne, vector borne, zoonotic diseases, vaccine-preventable diseases and social determinants of health)
Poster Session: Public Health
Katharina Schley, Dr. rer pol. (she/her/hers)
Director HTA, Value & Evidence
Pfizer Pharma GmbH
Berlin, Berlin, Germany
Jessica Presa, MD
Senior Director
Pfizer, Inc.
Collegeville, Pennsylvania, United States
Vincenza Snow, MD
Senior Director, Regional Medical and Scientific Affairs, North America
Pfizer Vaccines
Collegeville, PA, United States
Kathleen Dooling, MD
Pfizer Inc.
Collegeville, Pennsylvania, United States
Alejandro D. Cane, MD, PhD
North America Vaccines Medical Scientific Affairs Lead
Pfizer
Collegeville, Pennsylvania, United States
Paula Peyrani, MD
Senior Director
Pfizer, Inc
Collegeville, Pennsylvania, United States
Raymond Farkouh, PhD
Vaccines Health Economics and Outcomes Research
Pfizer, Inc.
Collegeville, Pennsylvania, United States
Shannon M. Sullivan, PhD
Evidera Inc.
Ivry-sur-Seine Cedex, Ile-de-France, France
J. Jaime Caro, MDCM, FRCPC, FACP
Evidera Inc.,
Waltham, Massachusetts, United States